Employee Stock Benefit Plans - Share-based Compensation Expense - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Sep. 30, 2023 |
Jun. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Employee Stock Benefit Plans | |||||
Share-based compensation expense | $ 7,906 | $ 7,067 | $ 50,849 | $ 19,757 | |
Research and Development Expense | |||||
Employee Stock Benefit Plans | |||||
Share-based compensation expense | 1,545 | 1,316 | 15,655 | 3,607 | |
Selling, General and Administrative Expenses | |||||
Employee Stock Benefit Plans | |||||
Share-based compensation expense | $ 6,361 | $ 5,751 | $ 34,283 | $ 16,150 | |
VectivBio Holding AG and its subsidiaries | |||||
Employee Stock Benefit Plans | |||||
Share-based compensation expense | $ 27,500 | ||||
VectivBio Holding AG and its subsidiaries | Research and Development Expense | |||||
Employee Stock Benefit Plans | |||||
Share-based compensation expense | 11,300 | ||||
VectivBio Holding AG and its subsidiaries | Selling, General and Administrative Expenses | |||||
Employee Stock Benefit Plans | |||||
Share-based compensation expense | $ 16,200 |